Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triamcinolone Acetonide vs Dexamethasone in Acute Primary Angle-Closure Phacoemulsification
ChiCTR1900021009Phase 4Completed
- Sponsor
- Chinese PLA General Hospital
- Start
- Jun 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of triamcinolone acetonide and dexamethasone in acute angle closure glaucoma (AACG) and senile cataract (ARC) (4 arms), sponsored by Chinese PLA General Hospital. Primary endpoints: Anterior chamber flare and Anterior chamber cells. Started Jun 2016; status: completed.
02
Drugs
triamcinolone acetonidedexamethasone
03
Conditions
acute angle closure glaucoma (AACG)senile cataract (ARC)
Beyond the preview
Go deeper on ChiCTR1900021009.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900021009.